Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 192 Records) |
Query Trace: Leukemia and IDH2[original query] |
---|
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation. Journal of hematology & oncology 2022 09 15 (1): 126. Kunadt Desiree, Stasik Sebastian, Metzeler Klaus H, Röllig Christoph, Schliemann Christoph, Greif Philipp A, Spiekermann Karsten, Rothenberg-Thurley Maja, Krug Utz, Braess Jan, Krämer Alwin, Hochhaus Andreas, Scholl Sebastian, Hilgendorf Inken, Brümmendorf Tim H, Jost Edgar, Steffen Björn, Bug Gesine, Einsele Hermann, Görlich Dennis, Sauerland Cristina, Schäfer-Eckart Kerstin, Krause Stefan W, Hänel Mathias, Hanoun Maher, Kaufmann Martin, Wörmann Bernhard, Kramer Michael, Sockel Katja, Egger-Heidrich Katharina, Herold Tobias, Ehninger Gerhard, Burchert Andreas, Platzbecker Uwe, Berdel Wolfgang E, Müller-Tidow Carsten, Hiddemann Wolfgang, Serve Hubert, Stelljes Matthias, Baldus Claudia D, Neubauer Andreas, Schetelig Johannes, Thiede Christian, Bornhäuser Martin, Middeke Jan M, Stölzel Friedrich, |
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. American journal of hematology 2022 Aug . Lachowiez Curtis A, Reville Patrick K, Kantarjian Hagop, Jabbour Elias, Borthakur Gautam, Daver Naval, Issa Ghayas, Furudate Ken, Tanaka Tomoyuki, Pierce Sherry, Tang Guilin, Patel Keyur P, Medeiros Jeffrey, Abbas Hussein A, Haddad Fadi, Hammond Daniel, Short Nicholas J, Maiti Abhishek, Yilmaz Musa, Sasaki Koji, Takahashi Koichi, Pemmaraju Naveen, Konopleva Marina, Garcia-Manero Guillermo, Ravandi Farhad, Kadia Tapan M, Loghavi Sanam, DiNardo Courtney |
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax. Leukemia research 2022 9 122 106942. Bewersdorf Jan Philipp, Shallis Rory M, Derkach Andriy, Goldberg Aaron D, Stein Anthony, Stein Eytan M, Marcucci Guido, Zeidan Amer M, Shimony Shai, DeAngelo Daniel J, Stone Richard M, Aldoss Ibrahim, Ball Brian J, Stahl Maximili |
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations. Cancer 2022 Sep . Ball Somedeb, Knepper Todd C, Deutsch Yehuda E, Samra Wassim, Watts Justin M, Bradley Terrence J, Chan Onyee, Hussaini Mohammad Omar, Zhang Ling, Sweet Kendra L, Kuykendall Andrew T, Talati Chetasi, Padron Eric, Komrokji Rami S, Lancet Jeffrey E, Sallman David |
Correlation Analysis and Prognostic Impacts of Biological Characteristics in Elderly Patients with Acute Myeloid Leukemia. Clinical interventions in aging 2022 17 1187-1197. Li Fengli, Li Na, Wang Anyou, Liu X |
[Analysis of Gene Mutation Characteristics and Prognosis of Elderly Patients with Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 2022 Jun 30 (3): 755-759. Zhou Nai-Cen, Li Guo-Hui, Qin Wei-Wei, Wang Wen-Qing, Guo Huai-Peng, Liu Cong, Liu |
Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes. Journal of clinical medicine 2022 5 11 (9): . Kang Dain, Jung Jin, Park Silvia, Cho Byung-Sik, Kim Hee-Je, Kim Yeojae, Lee Jong-Mi, Kim Hoon Seok, Ahn Ari, Kim Myungshin, Kim Yongg |
Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with RUNX1-RUNX1T1 or CBFB-MYH11 Fusions. Turkish journal of haematology : official journal of Turkish Society of Haematology 2022 4 39 (2): 84-93. Qin Wei, Chen Xiayu, Shen Hong Jie, Wang Zheng, Cai Xiaohui, Jiang Naike, Hua Haiyi |
[Gene Mutation and Clinical Characteristics of Patients with Acute Leukemia]. Zhongguo shi yan xue ye xue za zhi 2022 12 30 (6): 1693-1699. Yang Jie, Yang Yong-Bin, Wang Rui-Cang, Liu Jing-Yue, Li Yan, Yuan Jun, Li Jie, Zhang Xiao-Xia, Gao Xiao-Han, Hao Hong-Li |
BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia. Blood science (Baltimore, Md.) 2022 12 4 (4): 199-204. Zhang Yanqing, Bi Hailiang, Wang Ying, Chen Long, Pan Jiaqi, Xu Ping, Wang Wei, Yang Shaob |
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH -mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. medRxiv : the preprint server for health sciences 2023 9 . Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambind |
Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells. Leukemia 2023 7 . Anna Palau, Filip Segerberg, Michael Lidschreiber, Katja Lidschreiber, Aonghus J Naughton, Maria Needhamsen, Lisa Anna Jung, Maja Jagodic, Patrick Cramer, Sören Lehmann, Mattias Carlsten, Andreas Lennartss |
The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study. PloS one 2023 7 18 (7): e0289014. Sohaib M Al-Khatib, Obada Ababneh, Hassann Abushukair, Nour Abdo, Laith N Al-Eit |
Novel RUNX1 Variation in B-cell Acute Lymphoblastic Leukemia. Mediterranean journal of hematology and infectious diseases 2023 7 15 (1): e2023036. Egzona Qipa, Muradiye Acar, Sureyya Bozkurt, Murat Buyukdogan, Hazal B Sonmez, Muge Sayitoglu, Yucel Erbilgin, Zeynep Karaka?, Veysel S Hanç |
Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis. Translational cancer research 2023 7 12 (6): 1552-1564. Lifang Li, Jingxiong Ruan, Ning Zhang, Jia Dai, Xin Xu, Xudong Tian, Jian |
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis. BMC cancer 2023 6 23 (1): 527. Yao Qin, Kai Shen, Ting Liu, Hongbing |
Clinical and prognostic profile of SRSF2 and related spliceosome mutations in patients with acute myeloid leukemia. Molecular biology reports 2023 6 . Wenbo Jia, Xiaodong Guo, Yihong Wei, Jinting Liu, Can Can, Ruiqing Wang, Xinyu Yang, Chunyan Ji, Daoxin |
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, ECOG analysis. Blood advances 2023 6 . Sara Zarnegar-Lumley, Todd Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E Ries, Jim Wang, Amanda R Leonti, Matthew A Kutny, Fabiana Ostronoff, Jerald P Radich, Frederick R Appelbaum, Era L Pogosova-Agadjanyan, Kristen M O'Dwyer, Martin S Tallman, Mark R Litzow, Ehab Atallah, Todd M Cooper, Richard Aplenc, Omar I Abdel-Wahab, Alan S Gamis, Selina M Luger, Harry P Erba, Ross L Levine, E Anders Kolb, Derek L Stirewalt, Soheil Meshinchi, Katherine Tarlo |
Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of TP53 mutations in a real-world setting. Hematology (Amsterdam, Netherlands) 2023 6 28 (1): 2223866. Hong Liu, Yuye Shi, Shandong Tao, Yunjie Li, Chunling Wang, Liang |
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant. JAMA 2023 3 329 (9): 745-755. Dillon Laura W, Gui Gege, Page Kristin M, Ravindra Niveditha, Wong Zoë C, Andrew Georgia, Mukherjee Devdeep, Zeger Scott L, El Chaer Firas, Spellman Stephen, Howard Alan, Chen Karen, Auletta Jeffery, Devine Steven M, Jimenez Jimenez Antonio Martin, De Lima Marcos J G, Litzow Mark R, Kebriaei Partow, Saber Wael, Weisdorf Daniel J, Hourigan Christopher |
Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia. Clinical epigenetics 2023 3 15 (1): 54. Xu Xiaoyan, Wang Hong, Han Haohao, Yao Yifang, Li Xueqian, Qi Jiaqian, Cai Chengsen, Zhou Meng, Tang Yaqiong, Pan Tingting, Zhang Ziyan, Yang Jingyi, Wu Depei, Han Y |
[Analysis of epigenetic modification gene mutations among patients with acute myeloid leukemia]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 3 40 (4): 435-441. Wei Jifeng, Qiu Huiying, Zhou Hang, Chen Zhe, Miao Lei, Wang Ying, Zhao Lidong, Cai Zhim |
The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia. Cancer medicine 2023 3 . Chen Xian, Tian Chuchu, Hao Zhuanghui, Pan Lingang, Hong Minglin, Wei Wei, Muyey Daniel Muteb, Wang Hongwei, Chen Xiuh |
[Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 12 44 (10): 845-850. L L Wang, S N Ch |
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients. American journal of hematology 2023 12 . Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Antoine N Saliba, Mehrdad Hefazi Torghabeh, Mark R Litzow, William Hogan, Mithun Shah, Mrinal M Patnaik, Animesh Pardanani, Talha Badar, Hemant Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Arana Yi, Ayalew Teffe |
Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience. Clinical laboratory 2023 11 69 (11): . Eunhee Han, Soorack Ryu, Dohyang Kim, Eun-Ha Koh, Jung-Hyun Byun, Dong-Hyun L |
[Clinical features and survival analysis in non-M(3) acute myeloid leukemia patients with ASXL1 gene mutation]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (10): 833-840. Jia W B, Liu J T, Yang X Y, Wu H Y, Wei Y H, Can C, Wang R Q, He N, Gu C Y, Ma D X, Ji C |
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML. Leukemia research 2024 4 140 107497. Alberto Risueño, Wendy L See, Iryna Bluemmert, Stéphane de Botton, Courtney D DiNardo, Amir T Fathi, Andre C Schuh, Pau Montesinos, Paresh Vyas, Thomas Prebet, Anita Gandhi, Maroof Has |
A nomogram based on clinical features and molecular abnormalities for predicting the prognosis of patients with acute myeloid leukemia. Translational cancer research 2024 1 12 (12): 3432-3442. Yuancheng Guo, Yujie Niu, Haiping Liang, Xiaoxiao Yang, Jinli Jian, Xiao Tang, Bei L |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: